Mirum Pharmaceuticals, Inc. MIRM Finite-Lived Intangible Assets, Accumulated Amortization
Finite-Lived Intangible Assets, Accumulated Amortization at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s finite-lived intangible assets, accumulated amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s finite-lived intangible assets, accumulated amortization?
- Mirum Pharmaceuticals, Inc. (MIRM) reported finite-lived intangible assets, accumulated amortization of $67.44M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s finite-lived intangible assets, accumulated amortization changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s finite-lived intangible assets, accumulated amortization increased by 57.8% year-over-year, from $42.75M to $67.44M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s finite-lived intangible assets, accumulated amortization?
- Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s finite-lived intangible assets, accumulated amortization has grown at a 110.7% compound annual growth rate (CAGR), from $13.67M to $60.67M.